Gastrointestinal Stents Market is estimated to be valued at USD 2.01 billion in 2026 and is expected to reach USD 3.55 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 2.01 billion |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
8.50% |
2033 Value Projection: |
USD 3.55 billion |
The global gastrointestinal stents market covers a broad set of product type categories, including Self-Expandable Metallic Stents (SEMS), Plastic Stents, and Biodegradable Stents, used across applications such as Malignant Strictures, Benign Strictures (largest growth potential), and Fistula. Demand is supported by adoption among Hospitals, and Ambulatory Surgical Centers and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.
Market Dynamics:
Growing adoption across Malignant Strictures, and Benign Strictures (largest growth potential), rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global gastrointestinal stents market. A wider range of available options is making these solutions accessible to a broader base of users.
For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Ambulatory Surgical Centers. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global gastrointestinal stents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Boston Scientific Corporation, Cook Medical, Medtronic plc, S&G Biotech, Nitinol Devices & Components, Inc., Becton Dickinson and Company, Micro-Tech Endoscopy USA, Inc., Olympus Corporation, Nanjing Micro-Tech Medical Company Limited, Leufen Medical GmbH, and Hangzhou Endovision Technology Co, Ltd, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global gastrointestinal stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastrointestinal stents market.
Detailed Segmentation:
- Global Gastrointestinal Stents Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Self-Expandable Metallic Stents (SEMS)
- Plastic Stents
- Biodegradable Stents
- Balloon-Expandable Stents
- Others
- Global Gastrointestinal Stents Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Malignant Strictures
- Benign Strictures (largest growth potential)
- Fistula
- Perforations
- Others
- Global Gastrointestinal Stents Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Boston Scientific Corporation*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cook Medical
- Medtronic plc
- S&G Biotech
- Nitinol Devices & Components, Inc.
- Becton Dickinson and Company
- Micro-Tech Endoscopy USA, Inc.
- Olympus Corporation
- Nanjing Micro-Tech Medical Company Limited
- Leufen Medical GmbH
- Hangzhou Endovision Technology Co, Ltd
"*" marked represents similar segmentation in other categories in the respective section.